1. Executive Summary (Confidence: High)

Blue Ocean Ventures (BOV) is a premier Swiss investment firm focused on early-stage high-tech projects, primarily in medtech and diagnostics.^[36] Founded in 2007 by a team of serial entrepreneurs, the firm prides itself on its "blue ocean" strategy—investing in untapped markets where disruptive technology can establish clear leadership.^[37] With a portfolio that includes successful exits like Sensimed and Distalmotion, BOV targets companies with a pre-money valuation typically between CHF 3 and 10 million.^[37] The four general partners—Faris Sabeti, Emmanuel de Watteville, Sacha Haymoz, and Thomas Zehnder—bring deep operational experience in building medical device companies from inception to global exit, providing a "safer-than-usual" environment for institutional and private investors.^[15]